Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 8.54
(-2.95%)
CNY 8.54
(-2.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 953.98 Million | 1.08 Billion | 969.84 Million | 750.94 Million | 773.33 Million | 694.25 Million |
| Cost of Revenue | 218.75 Million | 247.28 Million | 201.15 Million | 165.32 Million | 162.58 Million | 145.71 Million |
| Gross Profit | 735.22 Million | 840.38 Million | 768.68 Million | 585.61 Million | 610.75 Million | 548.54 Million |
| Operating Expenses | 640.85 Million | 701.56 Million | 631.58 Million | 492.96 Million | 520.37 Million | 476.51 Million |
| Selling, General and Administrative Expenses | 588.74 Million | 577.54 Million | 525.67 Million | 409.99 Million | 436.71 Million | 405.42 Million |
| Research and Development Expenses | 38.13 Million | 21.58 Million | 20.37 Million | 13.29 Million | 21.1 Million | 31.83 Million |
| Other Expenses | 13.96 Million | 102.43 Million | 85.53 Million | 69.67 Million | 62.56 Million | 39.25 Million |
| Cost and Expenses | 860.23 Million | 948.84 Million | 832.73 Million | 658.29 Million | 682.96 Million | 622.22 Million |
| Operating Income | 93.74 Million | 122.16 Million | 117.11 Million | 86.35 Million | 83.43 Million | 74.58 Million |
| Interest Expense | 12.93 Million | 10.67 Million | 16.6 Million | 5.47 Million | 6.64 Million | 3 Million |
| Income Tax Expense | 11.54 Million | 5.49 Million | 16.04 Million | 9.83 Million | 12.17 Million | 10.96 Million |
| Earnings before Tax | 92.41 Million | 121.59 Million | 116.64 Million | 83.94 Million | 83.04 Million | 81.36 Million |
| Net Income | 80.87 Million | 111.51 Million | 99.47 Million | 72.54 Million | 71.42 Million | 70.97 Million |
| Earnings Per Share Basic | 0.35 | 0.51 | 0.45 | 0.33 | 0.32 | 0.31 |
| Earnings Per Share Diluted | 0.33 | 0.48 | 0.41 | 0.31 | 0.32 | 0.31 |
| Weighted Average Shares Outstanding | 231.78 Million | 228.03 Million | 225.22 Million | 225.28 Million | 226.4 Million | 227.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 244.54 Million | 243.8 Million | 244.69 Million | 241.26 Million | 226.4 Million | 229.51 Million |
| Gross Margin | 0.77 | 0.77 | 0.79 | 0.78 | 0.79 | 0.79 |
| EBIT Margin | 0.14 | 0.15 | 0.16 | 0.15 | 0.14 | 0.15 |
| Profit Margin | 0.08 | 0.10 | 0.10 | 0.10 | 0.09 | 0.10 |
| EBITDA | 130.06 Million | 157.46 Million | 160.3 Million | 108.3 Million | 107.84 Million | 99.3 Million |
| Earnings Before Tax Margin | 0.10 | 0.11 | 0.12 | 0.11 | 0.11 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 219.14 Million | 264.37 Million | 177.32 Million | 178.31 Million | 953.98 Million | 249.75 Million |
| Cost of Revenue | 60.67 Million | 72.47 Million | 39.31 Million | 41.39 Million | 218.75 Million | 57.02 Million |
| Gross Profit | 158.46 Million | 191.89 Million | 138.01 Million | 136.92 Million | 735.22 Million | 192.72 Million |
| Operating Expenses | 136.75 Million | 162.39 Million | 114.75 Million | 151.69 Million | 631.43 Million | 139.66 Million |
| Selling, General and Administrative Expenses | 269.85 Million | 95.27 Million | 107.28 Million | 37.24 Million | - | 177.08 Million |
| Research and Development Expenses | 8.51 Million | 16.16 Million | 5.23 Million | 15.21 Million | - | 10.08 Million |
| Other Expenses | -141.61 Million | -1.38 Million | -228.89 Thousand | -275.49 Thousand | -1.32 Million | -1.18 Million |
| Cost and Expenses | 197.42 Million | 234.87 Million | 154.06 Million | 193.08 Million | 850.18 Million | 196.69 Million |
| Operating Income | 32.33 Million | 19.13 Million | 18.54 Million | -10.26 Million | 93.74 Million | 48.57 Million |
| Interest Expense | 6.83 Million | 8.92 Million | 3.84 Million | 252.98 Thousand | 11.8 Million | 4.35 Million |
| Income Tax Expense | 1.54 Million | 2.98 Million | 2.74 Million | -3.69 Million | 11.54 Million | 6 Million |
| Earnings before Tax | 32.2 Million | 17.74 Million | 18.31 Million | -10.53 Million | 92.41 Million | 47.38 Million |
| Net Income | 30.66 Million | 14.76 Million | 15.57 Million | -6.84 Million | 80.87 Million | 41.38 Million |
| Earnings Per Share Basic | 0.14 | 0.06 | 0.07 | -0.03 | - | 0.18 |
| Earnings Per Share Diluted | 0.14 | 0.06 | 0.06 | -0.03 | - | 0.17 |
| Weighted Average Shares Outstanding | 216.62 Million | 231.1 Million | 231.38 Million | 231.49 Million | 231.78 Million | 231.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 216.62 Million | 231.1 Million | 250.35 Million | 231.49 Million | 244.54 Million | 247.51 Million |
| Gross Margin | 0.72 | 0.73 | 0.78 | 0.77 | 0.77 | 0.77 |
| EBIT Margin | 0.18 | 0.11 | 0.13 | -0.09 | - | 0.21 |
| Profit Margin | 0.14 | 0.06 | 0.09 | -0.04 | 0.08 | 0.17 |
| EBITDA | 39.04 Million | 28.3 Million | 23.2 Million | -16.43 Million | - | 52.11 Million |
| Earnings Before Tax Margin | 0.15 | 0.07 | 0.10 | -0.06 | 0.10 | 0.19 |
PROX
SEAL-PA
HTFC
PHGE
VLVOF
OSSIF